$AGIO AGIOS PHARMACEUTICALS, INC. Insider Trading Week 13/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. in week 13/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.69 | 3,053 | 2,099 | 114,271 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.47 | 947 | 443 | 117,324 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 38.08 | 4,000 | 152,320 | 0 | 4 K to 0 (-100.00 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 3,053 | 2,099 | 4,000 | 947 to 4 K (+322.39 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.47 | 947 | 443 | 947 | 0 to 947 |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 12,000 | 3,630 | 274,040 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 38.08 | 12,000 | 456,960 | 209,090 | 221.1 K to 209.1 K (-5.43 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 12,000 | 3,630 | 221,090 | 209.1 K to 221.1 K (+5.74 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 4,500 | 2,104 | 285,590 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 12,000 | 5,610 | 290,090 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 18,000 | 8,415 | 302,090 | |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 38.08 | 4,500 | 171,360 | 30,000 | 34.5 K to 30 K (-13.04 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 4,500 | 2,104 | 34,500 | 30 K to 34.5 K (+15.00 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 12,000 | 5,610 | 30,000 | 18 K to 30 K (+66.67 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 18,000 | 8,415 | 18,000 | 0 to 18 K |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Tessier-Lavigne Marc | Director | Buy | P | 18.00 | 55,555 | 999,990 | 101,009 | 45.5 K to 101 K (+122.22 %) |
| Apr 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | P | 18.00 | 8,333 | 149,994 | 44,333 | 36 K to 44.3 K (+23.15 %) |